Western Blotting (WB), Enzyme Immunoassay (EIA), Functional Studies (Func)
Spezifität
This MCP1 antibody reacts with natural and recombinant Human MCP-1. Does not react with Human Interleukin-8 (IL-8) and other Human cytokines tested such as Interleukin-1 beta (IL1 beta), Serum Amyloid A (SAA) and Epidermal Growth Factor (EGF).
ELISA: React with Human MCP-1. Can be used as a Capture antibody in Sandwich ELISAapplications for human MCP-1 detection in combination with a monoclonaltracer/detection antibody. Suggested Capture Coating Dose: 0.3 μg/well. Substrate: TMB. If the above suggested conditions are followed approximately 1.5 pg/mL ofMCP-1 in serum/plasma or 4 pg/mL of MCP-1 in medium can be detected with an assayrange of 0-1600 pg/mL. Neutralizing: Tests on the ability to inhibit monocyte chemotaxis toward 1 nM recombinanthuman MCP-1 in blindwell chambers showed that the antibodies were particularly effectiveat blocking MCP-1 activity at a concentration of 0.5 μg/mL. It was also found that S-14 couldinhibit the function of native MCP-1 at concentrations similar to inhibitory doses forrecombinant MCP-1. Western Blot: MCP1 antibody at 0.1-1.0 μg/mL will allow visualization of 0.1 μg/lane ofhuman MCP1.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Rekonstitution
Restore with double distillated water to adjust the final concentration to 1.00 mg/mL
This chemotactic factor attracts monocytes and basophils but not neutrophils or eosinophils and augments monocyte anti-tumor activity. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. It may be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.Synonyms: C-C motif chemokine 2, HC-11, HC11, MCAF, MCP-1, Monocyte chemoattractant protein 1, Monocyte chemotactic and activating factor, Monocyte chemotactic protein 1, Monocyte secretory protein JE, SCYA2, Small-inducible cytokine A2